Table 1 Altered lipid profile in Epac−/− mice.
WT | Epac1−/− | Epac2−/− | Epac1/2−/− | ||
---|---|---|---|---|---|
Control | |||||
Plasma, mmol/l | C | 2.75 ± 0.09 | 2.26 ± 0.21aa | 2.25 ± 0.13aa | 2.37 ± 0.21aa |
HDL-C | 2.38 ± 0.03 | 1.91 ± 0.37aaa | 1.99 ± 0.18aa | 1.90 ± 0.16aaaa | |
LDL-C | 0.20 ± 0.05 | 0.21 ± 0.03 | 0.12 ± 0.04 | 0.23 ± 0.10 | |
UC | 0.80 ± 0.08 | 0.75 ± 0.06 | 0.74 ± 0.04 | 0.78 ± 0.05 | |
TG | 1.19 ± 0.33 | 1.34 ± 0.14 | 1.44 ± 0.20 | 1.54 ± 0.31a | |
NEFA | 0.23 ± 0.14 | 0.017 ± 0.04 | 0.10 ± 0.13 | 0.11 ± 0.01 | |
PL | 2.99 ± 0.12 | 2.60 ± 0.03a | 2.56 ± 0.16aa | 2.69 ± 0.16a | |
Liver, μmol/g | C | 6.35 ± 0.43 | 7.77 ± 2.09 | 6.35 ± 0.51 | 6.69 ± 0.34 |
TG | 5.25 ± 0.91 | 5.73 ± 0.46 | 8.86 ± 3.07 | 5.01 ± 0.50 | |
NEFA | 0.61 ± 0.10 | 0.55 ± 0.08 | 0.55 ± 0.05 | 0.55 ± 0.06 | |
PL | 21.36 ± 0.76 | 20.58 ± 0.86dd | 21.47 ± 0.69 | 22.54 ± 0.54 | |
36 h post PH | |||||
Plasma, mmol/l | C | 1.62 ± 0.17bbbb | 1.68 ± 0.17bbb | 1.58 ± 0.23bbbb | 1.76 ± 0.22bbbb |
HDL-C | 1.21 ± 0.19bbbb | 1.25 ± 0.13bbbb | 1.17 ± 0.16bbbb | 1.22 ± 0.18bbbb | |
LDL-C | 0.29 ± 0.04ccc | 0.41 ± 0.09bb | 0.32 ± 0.13bbb, cccc | 0.54 ± 0.02bbbb | |
UC | 0.75 ± 0.08 | 0.70 ± 0.05 | 0.73 ± 0.08 | 0.75 ± 0.09 | |
TG | 0.68 ± 0.08bbbb | 0.65 ± 0.05bbbb | 0.57 ± 0.14bbbb | 0.54 ± 0.16bbbb | |
NEFA | 0.16 ± 0.11 | 0.27 ± 0.15 | 0.23 ± 0.18 | 0.14 ± 0.07 | |
PL | 1.77 ± 0.19bbbb | 1.74 ± 0.16bbbb | 1.68 ± 0.23bbbb | 1.74 ± 0.24bbbb | |
Liver, μmol/g | C | 9.22 ± 0.82bbbb | 9.95 ± 0.90bb, c | 8.91 ± 1.01bbb | 7.81 ± 1.49 |
TG | 78.78 ± 45.62bb | 39.47 ± 20.90 | 56.04 ± 46.97 | 7.68 ± 1.65 | |
NEFA | 1.22 ± 0.41 | 0.94 ± 0.22 | 0.98 ± 0.41 | 0.66 ± 0.10 | |
PL | 19.80 ± 1.10bb | 19.47 ± 0.91 | 20.38 ± 0.91 | 20.24 ± 0.80bbb |